Doxycycline Is a Cost-effective Therapy for Hospitalized Patients With Community-Acquired Pneumonia
- 8 February 1999
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 159 (3), 266-270
- https://doi.org/10.1001/archinte.159.3.266
Abstract
Background Doxycycline has a high degree of activity against many common respiratory pathogens and has been used in the outpatient management of lower respiratory tract infections, including pneumonia. Objective To evaluate the efficacy of intravenous doxycycline as empirical treatment in hospitalized patients with mild to moderately severe community-acquired pneumonia. Patients and Methods We conducted a randomized prospective trial to compare the efficacy of intravenous doxycycline with other routinely used antibiotic regimens in 87 patients admitted with the diagnosis of community-acquired pneumonia. Forty-three patients were randomized to receive 100 mg of doxycycline intravenously every 12 hours while 44 patients received other antibiotic(s) (control group). The 2 patient groups were comparable in their clinical and laboratory profiles. Results The mean ± SD interval between starting an antibiotic and the clinical response was 2.21 ± 2.61 days in the doxycycline group compared with 3.84 ± 6.39 days in the control group (P =.001). The mean ± SD length of hospitalization was 4.14 ± 3.08 days in the doxycycline group compared with 6.14 ± 6.65 days in the control group (P =.04). The median cost of hospitalization was $5126 in the doxycycline group compared with $6528 in the control group (P =.04). The median cost of antibiotic therapy in the doxycycline-treated patients ($33) was significantly lower than in the control group ($170.90) (P<.001). Doxycycline was as efficacious as the other regimens chosen for the treatment of community-acquired pneumonia. Conclusion Doxycycline is an effective and inexpensive therapy for the empirical treatment of hospitalized patients with mild to moderately severe community-acquired pneumonia.Keywords
This publication has 6 references indexed in Scilit:
- Doxycycline Activity Against Streptococcus pneumoniaeChest, 1995
- The problems of treating atypical pneumoniaJournal of Antimicrobial Chemotherapy, 1993
- Trends in Antimicrobial Resistance of Clinical Isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990)Clinical Infectious Diseases, 1992
- Microbial Etiology of Acute Pneumonia in Hospitalized PatientsChest, 1992
- Community-Acquired Pneumonia Requiring Hospitalization: 5-Year Prospective StudyClinical Infectious Diseases, 1989
- Comparison of spiramycin and doxycycline in the treatment of lower respiratory infections in general practiceJournal of Antimicrobial Chemotherapy, 1988